» Authors » Kostas Archontogeorgis

Kostas Archontogeorgis

Explore the profile of Kostas Archontogeorgis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 258
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Voulgaris A, Archontogeorgis K, Papanas N, Pilitsi E, Nena E, Xanthoudaki M, et al.
Clin Respir J . 2019 Aug; 13(11):708-715. PMID: 31433558
Introduction: Accumulating evidence suggests that cardiovascular disease (CVD) is highly prevalent among patients with concurrent obstructive sleep apnoea syndrome (OSAS) and chronic obstructive pulmonary disease, otherwise known as overlap syndrome...
12.
Archontogeorgis K, Papanas N, Rizos E, Nena E, Zissimopoulos A, Tsigalou C, et al.
Medicina (Kaunas) . 2019 May; 55(5). PMID: 31137600
: Obstructive sleep apnea syndrome (OSAS) is associated with cardiovascular and metabolic risk factors, such as insulin resistance. Furthermore, OSAS has been associated with decreased levels of vitamin D (Vit...
13.
Ragia G, Archontogeorgis K, Simmaco M, Gentile G, Borro M, Zissimopoulos A, et al.
OMICS . 2018 Dec; 23(1):45-53. PMID: 30562127
Obstructive sleep apnea syndrome (OSAS) is a multifactorial and common disorder affecting 10-17% of men and 3-9% of women. A low vitamin D serum concentration has been reportedly linked to...
14.
Archontogeorgis K, Nena E, Papanas N, Steiropoulos P
Breathe (Sheff) . 2018 Sep; 14(3):206-215. PMID: 30186518
Key Points: Vitamin D insufficiency prevalence is increasing worldwide and presents with similar comorbidities and risk factors to OSAS.The nonskeletal actions of vitamin D may contribute to the development of...
15.
Archontogeorgis K, Voulgaris A, Papanas N, Nena E, Froudarakis M, Mikhailidis D, et al.
Clin Appl Thromb Hemost . 2018 Jul; 24(8):1216-1222. PMID: 30016881
Evidence suggests that there is platelet activation in obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary disease (COPD). Our objective is to evaluate mean platelet volume (MPV) and platelet...
16.
Voulgaris A, Archontogeorgis K, Nena E, Tsigalou C, Xanthoudaki M, Kouratzi M, et al.
Sleep Breath . 2018 Jun; 23(1):161-169. PMID: 29946947
Purpose: Obstructive sleep apnea syndrome (OSAS) has been recently proposed as an independent risk factor for chronic kidney disease. Cystatin C (Cyst C) and neutrophil gelatinase-associated lipocalin (NGAL) are novel...
17.
Archontogeorgis K, Voulgaris A, Nena E, Strempela M, Karailidou P, Tzouvelekis A, et al.
Cardiol Res Pract . 2018 May; 2018:6572785. PMID: 29707392
Objectives: Obstructive sleep apnea syndrome (OSAS) is associated with increased cardiovascular morbidity and mortality. The aim of this study was to assess whether the 10-year risk for cardiovascular disease in...
18.
Archontogeorgis K, Nena E, Papanas N, Rizzo M, Voulgaris A, Xanthoudaki M, et al.
Metab Syndr Relat Disord . 2018 Apr; 16(4):190-196. PMID: 29608396
Background: Numerous studies have indicated that obstructive sleep apnea syndrome (OSAS), may contribute to the development of metabolic syndrome (MetS) and diabetes. Moreover, OSAS has been associated with lowered vitamin...
19.
Archontogeorgis K, Nena E, Tsigalou C, Voulgaris A, Xanthoudaki M, Froudarakis M, et al.
Pulm Med . 2016 Nov; 2016:8081723. PMID: 27843647
. Obstructive sleep apnea syndrome (OSAS) is associated with systemic inflammation and increased risk of cardiovascular and chronic kidney disease. Cystatin C (Cyst C) is a novel biomarker of both...
20.
Archontogeorgis K, Lanfranco A, Koulelidis A, Froudarakis M
Monaldi Arch Chest Dis . 2016 Jul; 81(1-2):735. PMID: 27374214
Bilateral empyema associated to infectious pericarditis is an extremely rare, yet life-threatening condition. Pleuroscopy-medical thoracoscopy has proved its efficacy in series of patients with empyema. Yet, all reported cases treated...